Track MDGL and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Madrigal Pharmaceuticals Inc
Four Tower Bridge, West Conshohocken, PA, United States, 19428
IPO
2007
Employees
915
Industry
Biotechnology
Sector
Healthcare
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q1 202615-15
0
Q4 20255-5
0
2-quarter cumulative
20 sells0 buys
Analyst Ratings
5 analysts covering
Buy60%recommend buy
Buy
3
Hold
1
Sell
1